Paradigm Peptides Shut Down: What Happened and the Safe Alternative (2026)
On December 10, 2025, Paradigm Peptides owner Matthew Kawa pleaded guilty in federal court, investigators found that products sold as SARMs contained testosterone, and paradigmpeptides.com is no longer operational. If you relied on them, here is what the record says and the prescribed, pharmacy-grade path that stays accountable.
If you are looking for a Paradigm Peptides alternative, here is why: on December 10, 2025, Paradigm Peptides owner Matthew Kawa (Paradigm R.E. LLC, paradigmpeptides.com) and a co-defendant pleaded guilty in federal court in the U.S. District Court for the Northern District of Indiana. According to the record, federal investigators determined that many products advertised and sold as SARMs in fact contained testosterone, a controlled substance, and that the SARM, hCG, and peptide products were unapproved new drugs.
The paradigmpeptides.com website is no longer operational. This guide lays out the verified facts of what happened, why a grey-market vendor with no prescriber and no licensed pharmacy is fragile by design, and the safe way forward: a prescribed, pharmacy-grade path where a licensed physician prescribes, an FDA-registered 503A pharmacy compounds, a Certificate of Analysis verifies each batch, and pru prices the peptide at cost. pru is built only for that path and it does not vanish.
Paradigm Peptides ended in a federal guilty plea, and here is the safe alternative
Paradigm Peptides ended in the federal court record, not a business decision. On December 10, 2025, the owner and a co-defendant pleaded guilty, investigators found that products advertised as SARMs contained testosterone, a controlled substance, and paradigmpeptides.com is no longer operational. The safe alternative is not another grey-market site selling vials labeled for research use only, where you cannot be sure what is in the vial.
It is a prescribed, pharmacy-grade path: real peptides, but ordered through a licensed telehealth provider where a physician confirms the peptide is appropriate for you and a 503A pharmacy fills it with a Certificate of Analysis that verifies each batch. That is the difference between a product no one stands behind and a medicine you can stand behind.
THE ONE LINE THAT MATTERSWhen products advertised as one thing were found to contain a controlled substance, the failure was accountability. A vendor with no prescriber, no licensed pharmacy, and no verified testing can put anything in the vial and vanish. A prescribed, pharmacy-grade path cannot. pru only does that path.

What happened to Paradigm Peptides
The verified facts are on the record. On December 10, 2025, Paradigm Peptides owner Matthew Kawa (Paradigm R.E. LLC, which operated paradigmpeptides.com) and a co-defendant pleaded guilty in the U.S. District Court for the Northern District of Indiana. According to the record, federal investigators determined that many products advertised and sold as SARMs in fact contained testosterone, a controlled substance. Investigators also determined that the SARM, hCG, and peptide products were unapproved new drugs. The paradigmpeptides.com website is no longer operational.
WHAT THE RECORD SAYSConfirmed on the record: a federal guilty plea on December 10, 2025 tied to Paradigm Peptides; products advertised as SARMs found to contain testosterone, a controlled substance; the SARM, hCG, and peptide products determined to be unapproved new drugs; and the website no longer operational. This guide states those facts and nothing beyond them.
The customer impact is the part that matters most if you are reading this. A source you may have relied on is gone, and the record shows that some of what it sold was not what the label said. There was no prescriber to call, no licensed pharmacy on the hook, and no accountable party to answer for what was in the vial. That is not an accident of one vendor. It is the built-in risk of buying from a grey-market seller in the first place.
Why this happens to grey-market vendors
A case like this is not a freak event. It is the built-in risk of the grey-market model. A research-chemical vendor sells vials labeled for laboratory research only, which is how it stays outside the rules that apply to anything meant to go into a person. That same structure is what leaves buyers exposed.
When there is no prescriber, no licensed pharmacy, and no regulated party standing behind the product, there is also no one obligated to keep serving you, no one verifying that the vial contains what the label claims, and no one to answer for it when the record shows otherwise.
- No prescriber. No licensed clinician reviewed your history or is responsible for your care, so no one is obligated to keep it going.
- No licensed pharmacy. No 503A or 503B facility, no pharmacist oversight, and no dispensing record tied to you.
- No verified testing. A seller-attested Certificate of Analysis is only as durable as the seller. In the Paradigm case the federal record shows products advertised as SARMs contained testosterone, a controlled substance, so buyers could not know what was in the vial.
- No recourse when it ends. No transferable prescription and no regulated party to make you whole. When the site goes dark or the record catches up, your money and your supply go with it, as buyers saw when paradigmpeptides.com went offline.
THE LESSONThe category is fragile by design. A grey-market seller with no prescriber, no licensed pharmacy, and no verified testing can mislabel a product, sell it, and disappear, whether by a voluntary closure, an FDA action, or a federal prosecution. The peptides may be real, or they may not be what the label says.
The durable, accountable, legal, verified alternative keeps the real medicine but replaces the fragile part. For more on the two tiers, see pharmacy-grade vs grey-market peptides and research-grade vs pharmacy-grade peptides.
The safe pharmacy-grade alternative
The safe alternative is pharmacy-grade. A licensed physician prescribes, an FDA-registered 503A pharmacy compounds the peptide for you as an individual, a Certificate of Analysis verifies each batch, and, with pru, the peptide is priced at cost. Every part that a grey-market vendor skips is added back, and every part that let the Paradigm case happen, mislabeling, no oversight, no verified testing, is replaced with an accountable, regulated one. Here is the contrast, line by line.
| What matters | A grey-market vendor | pru (pharmacy-grade) |
|---|---|---|
| Do you know what is in the vial? | Not reliably; in the Paradigm case, products advertised as SARMs were found to contain testosterone, a controlled substance | Yes; a Certificate of Analysis verifies every batch |
| Prescriber | None; no clinician at any step | Licensed U.S. physician confirms the peptide is appropriate for you, or advises against it |
| Who fills it | Research-chemical supplier; no pharmacy in the chain | FDA-registered 503A compounding pharmacy |
| Can it disappear? | Yes; a vendor with no prescriber or licensed pharmacy can go offline, as paradigmpeptides.com did | No; pru is an accountable, LegitScript-certified telehealth and pharmacy path |
| What is even sold | May include SARMs, hCG, and research chemicals, which the Paradigm record found were unapproved new drugs | Compounded peptides only; pru does not sell research-grade material, SARMs, testosterone, or hCG |
| Pricing | Per-vial retail, paid up front, with no verification of the product | Peptides at cost, itemized, plus a separate $50/mo membership (billed annually) |
The trade is clear. A grey-market vendor gives you a vial and a disclaimer, and the label may not match what is inside. pru gives you a prescriber, a licensed pharmacy, a batch-verified fill, and at-cost pricing you can read line by line, from a provider that stays accountable. When you start on a 3-month plan, pru's compounded semaglutide comes to about $60 a month and tirzepatide to about $93 a month, because the medication is priced at cost with no markup.
Membership is separate: $50 a month billed annually for unlimited at-cost access, so the savings compound with every vial and you can stack more than one peptide without a markup on any of them. To vet any provider yourself, see how to verify a peptide source and where to buy peptides safely online.
How pru works, at cost
pru is a LegitScript-certified DTC membership telehealth platform built only for compounded peptides. pru's content guides you to the peptide that fits your goal and you choose it, a licensed physician confirms it is appropriate for you (or advises against it) and sets the dose, an FDA-registered 503A pharmacy compounds and fills it with a Certificate of Analysis, and the peptide is priced at cost, itemized, with no markup on the medicine.
When you start on a 3-month plan, your price for compounded semaglutide comes to about $60 a month (about $93 a month for tirzepatide), the lowest, because the medication is at cost.
Membership is separate: $50 a month billed annually for unlimited access to the platform and clinician messaging, so the savings compound with every vial and you can stack more than one peptide without a markup on any of them. pru offers compounded peptides, including semaglutide, tirzepatide, NAD+, glutathione, sermorelin, GHK-Cu cream, PT-141 nasal spray, and oxytocin, as injection, nasal spray, or GHK-Cu cream. pru does not sell research-grade material, SARMs, testosterone, or hCG.
Browse everything available now in the full catalog, or see the at-cost pricing. If you were buying for weight care, the weight loss & metabolism category has the GLP-1 options; for NAD+ and longevity, see cellular health.
Losing a supplier this way is a hard reminder that the vial is only as trustworthy as the party behind it, but it is the moment to be proactive about your health and move onto a prescribed, tested path that stays accountable to you. Take the next step whenever you are ready.
WHERE PRU SITSpru works only in the prescribed, pharmacy-grade tier: individualized, 503A-compounded peptides documented with a Certificate of Analysis. Pharmacy-grade means a physician prescribed it and a licensed pharmacy made it. It does not mean FDA-approved.
Related reading
- Research-Grade Peptide Alternatives
- Pharmacy-Grade vs Grey-Market Peptides
- How to Spot Fake Peptides
- How to Verify a Peptide Source
- Where to Buy Peptides Safely Online
- Peptide Vendor Shutdowns in 2026
Common questions
Sources & further reading
- U.S. District Court for the Northern District of Indiana, federal court record: guilty plea entered December 10, 2025 by Paradigm Peptides owner Matthew Kawa (Paradigm R.E. LLC, operator of paradigmpeptides.com) and a co-defendant; federal investigators determined many products advertised and sold as SARMs contained testosterone, a controlled substance, and that the SARM, hCG, and peptide products were unapproved new drugs. Accessed July 2026.
- paradigmpeptides.com (no longer operational). Accessed July 2026.
- U.S. Food and Drug Administration. Human Drug Compounding and Compounding and the FDA: Questions and Answers (503A; compounded drugs are not FDA-approved). fda.gov. Accessed July 2026.
- pru catalog, category, and pricing pages. joinpru.com. Accessed July 2026.
- Compounded peptide pricing (internal pru research): pru compounded semaglutide medication approx. $60/mo and tirzepatide approx. $93/mo on a 3-month starter plan, priced at cost, with a separate $50/mo membership (billed annually, unlimited at-cost access). Accessed July 2026.
- LegitScript. Healthcare Merchant Certification. legitscript.com. Accessed July 2026.